Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can mild cognitive impairment and Alzheimer’s disease be diagnosed by monitoring a miRNA triad in the blood?

10 May 2022

Abstract excerpt

Objectively diagnosing age-related cognitive impairment (ACI), mild cognitive impairment (MCI), and early-stage Alzheimer's disease (AD) is a difficult task, as most cognitive impairment is clinically established via questionnaires, history, and physical examinations. A recent study has suggested that monitoring a miRNA triad, miR-181a-5p, miR-146a-5p, and miR-148a-3p can identify ACI and its progression to MCI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to MicroRNA in disease regulation
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35537095
DOI: 10.1111/acel.13627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can mild cognitive impairment and Alzheimer’s disease be diagnosed by monitoring a miRNA triad in the blood?PMID 35537095Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Plasma microRNA biomarkers for detection of mild cognitive impairmentSemantic proximity Read ↗

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophySemantic proximity Read ↗

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

Circulating long noncodingRNAs in Mild Cognitive Impairment patients’ bloodSemantic proximity Read ↗

Literature-Identified Serum miRNA Signatures for Cognitive Decline: Integrated Analysis and Machine-Learning Diagnostics in Alzheimer’s DiseaseSemantic proximity Read ↗

A multi-omics approach identifies a blood-based miRNA signature of cognitive decline in two large observational trialsSemantic proximity Read ↗

Blood serum miRNA: Non-invasive biomarkers for Alzheimer's diseaseSemantic proximity Read ↗

Machine learning to detect Alzheimer’s disease from circulating non-coding RNAsSemantic proximity Read ↗

Blood-Based Circular RNAs Enable Early and Accurate Alzheimer’s Disease DiagnosisSemantic proximity Read ↗

Plasma microRNA vary in association with the progression of Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.